BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Epstein-Barr virus envelope glycoprotein gp350 (BLLF1); ferritin

September 3, 2015 7:00 AM UTC

Mouse studies suggest vaccine nanoparticles engineered to display the BLLF1 ectodomain could help prevent EBV infection. The vaccine nanoparticles consisted of the BLLF1 ectodomain fused to the N-term...